Japan’s Shionogi Pharmaceutical Company announced on the 25th that it has applied to the Japanese Ministry of Health, Labour and Welfare for the production and sales license of the new coronavirus oral drug. If recognized, it will be the first Japanese-made oral drug for the new coronavirus to be approved for marketing. (CCTV, Zeta)
Source:Daily Economic News